Femme et Homme
- | Pays :
- Saudi Arabia
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to determine if the combination of Gemcitabine, Oxaliplatin and Erlotinib in the treatment of patients with pancreatic cancer will provide increased clinical benefits and improvement in their quality of life.
Critère d'inclusion
- Pancreatic cancer